Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 12 analysts

Protagonist Therapeutics Inc has a share price target of US$ 96, revenue growth forecast of -84.6%, and profit growth estimate of -137.3% for FY25, based on top 12 analyst calls.